Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 2Recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Breast Neoplasms 70Prostatic Neoplasms 66Carcinoma, Non-Small-Cell Lung 65Neoplasms 45Multiple Myeloma 43Lung Neoplasms 37Colorectal Neoplasms 35Melanoma 31Lymphoma, Non-Hodgkin 28Lymphoma 27Leukemia, Myeloid, Acute 27Squamous Cell Carcinoma of Head and Neck 26Pancreatic Neoplasms 26Neoplasm Metastasis 26Ovarian Neoplasms 25Carcinoma, Renal Cell 24Leukemia, Lymphocytic, Chronic, B-Cell 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Endometrial Neoplasms 21Sarcoma 20Carcinoma, Hepatocellular 20Urinary Bladder Neoplasms 19Glioma 19Stomach Neoplasms 18Uterine Cervical Neoplasms 17Recurrence 17Head and Neck Neoplasms 17Rectal Neoplasms 16Lymphoma, Mantle-Cell 16Triple Negative Breast Neoplasms 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Hematologic Diseases × 30 days × Clear all
NCT01287000 2026-05-22

Gulf Long-Term Follow-Up Study

National Institutes of Health Clinical Center (CC)

Active not recruiting
32,658 enrolled

Psychological Well-Being, Cardiovascular Diseases, Hematologic Diseases, Immune System Diseases, Neoplasms, Respiratory Aspiration

NCT05186753 2026-05-22

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Cogent Biosciences, Inc.

Phase 2 Active not recruiting
237 enrolled
Myeloid

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡